← Leaderboards
Yunchao Su
University Of Florida
$4,504,620
Attributed
$7,081,514
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $722K · FY2008–25$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,081,514 · 4
VA$0 · 2
By mechanism
R01$6,935,114 · 3
R03$146,400 · 1
I01$0 · 2
Top collaborators
- Yuqing Huo4 shared
- Alexander D Verin4 shared
Most similar at University Of Florida
Same institution · by research overlap
- Lyle L Moldawer$27,709,476
- Azra Bihorac$9,708,570
- David C Holden$126,542
- Nadeem Khan$2,271,953
- Scott Charles Brakenridge$2,194,663
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsMediatingLungInterdisciplinary ApproachEndothelial CellsKnock-OutEndotheliumPreventBlood VesselsLeadCell ProliferationHypoxiaCytoskeletonOverexpressionActinsMammalian CellPhosphorylationCalpainPlayFamilyAttenuatedCaspaseProductionProteolysis
Grant awards (22)
Calpain/talin/MLCP axis in pulmonary endothelial barrier regulation$721,969
R01 · FY2025 · HL
Calpain/talin/MLCP axis in pulmonary endothelial barrier regulation$707,530
R01 · FY2024 · HL
Calpain-mediated lung endothelial barrier modulation in acute lung injury$0
I01 · FY2024 · VA · contact PI
Calpain/talin/MLCP axis in pulmonary endothelial barrier regulation$721,969
R01 · FY2023 · HL
Calpain-mediated lung endothelial barrier modulation in acute lung injury$0
I01 · FY2023 · VA · contact PI
Calpain/talin/MLCP axis in pulmonary endothelial barrier regulation$721,969
R01 · FY2022 · HL
Calpain-mediated lung endothelial barrier modulation in acute lung injury$0
I01 · FY2022 · VA · contact PI
PFKFB3 in vascular remodeling$570,088
R01 · FY2020 · HL · contact PI
PFKFB3 in vascular remodeling$570,088
R01 · FY2019 · HL · contact PI
PFKFB3 in vascular remodeling$570,088
R01 · FY2018 · HL · contact PI
Airway and Lung Vascular Remodeling in COPD$0
I01 · FY2018 · VA · contact PI
PFKFB3 in vascular remodeling$570,088
R01 · FY2017 · HL · contact PI
Airway and Lung Vascular Remodeling in COPD$0
I01 · FY2017 · VA · contact PI
Airway and Lung Vascular Remodeling in COPD$0
I01 · FY2016 · VA · contact PI
Airway and Lung Vascular Remodeling in COPD$0
I01 · FY2015 · VA · contact PI
Calpain Activates Intracellular TGF-beta1 in Pulmonary Hypertension$71,400
R03 · FY2013 · HL · contact PI
eNOS-actin Interaction and Oxygen in Lung Endothelium$363,825
R01 · FY2012 · HL · contact PI
Calpain Activates Intracellular TGF-beta1 in Pulmonary Hypertension$75,000
R03 · FY2012 · HL · contact PI
eNOS-actin Interaction and Oxygen in Lung Endothelium$367,500
R01 · FY2011 · HL · contact PI
eNOS-actin Interaction and Oxygen in Lung Endothelium$367,500
R01 · FY2010 · HL · contact PI
eNOS-actin Interaction and Oxygen in Lung Endothelium$367,500
R01 · FY2009 · HL · contact PI
eNOS-actin Interaction and Oxygen in Lung Endothelium$315,000
R01 · FY2008 · HL · contact PI